Substances · Cathinone derivatives
NEP
- Preferred name
- NEP
- IUPAC name
- 2-(ethylamino)-1-phenylpentan-1-one
- Parent CAS number (reference)
- 779974-89-9
- Molecular formula
- C13H19NO
- Molecular weight
- 205.3 g/mol
- InChIKey
- QQAHEGDXEXIQPR-UHFFFAOYSA-N
- PubChem
- CID 205593
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
N-ethyl-Pentedrone N-Ethylpentedrone N-Ethylnorpentedrone
Verified Neurochemical & Toxicological Intelligence
NEP (N-Ethylpentedrone / N-Ethylnorpentedrone)
Receptor Telemetry & Mechanism of Action
Pure monoamine transporter uptake blocker (NDRI) without substrate-induced release. In HEK293 human transporter assays (Eshleman et al., 2019), NEP potently inhibits hNET (IC50 = 101 ± 24 nM, Ki = 700 ± 180 nM) and hDAT (IC50 = 165 ± 43 nM, Ki = 182 ± 22 nM), while serotonin reuptake inhibition is ~64-fold weaker (hSERT IC50 = 10,500 ± 2,000 nM, Ki = 8,400 ± 2,100 nM). Human observational data confirm brisk heart-rate (+22.3 bpm) and systolic BP (+20.6 mmHg) increases alongside alertness, openness, and sociability.
Biotransformation & Active Metabolites
Monitored and risk-assessed by EUDA (2025–2026); specific human plasma pharmacokinetic parameters (Cmax, elimination half-life) have not yet been published in controlled trials.
Temporal Pharmacokinetics
Smooth, confident, NDRI-type stimulation offering brisk wakefulness, talkativeness, social openness, and mild tactile pleasure with less initial peripheral harshness than Hexen.
- Onset 10–25 minutes oral (1–8 minutes mucosal)
- Peak Window 1–2 hours oral (30–60 minutes mucosal)
- Total Window 4–6 hours oral (1–3 hours mucosal; cardiovascular elevation lasts ~4 hours)
- Residual / Half-Life 1–4 hours after a single dose, extending up to 12–24 hours of insomnia after repeated exposure; human plasma half-life is unverified.
Roughly 3–4 times more potent by weight than MMC/CMC cathinones: active from 10 mg, with strong stimulation at 40–60 mg. Critically, mood elevation declines rapidly within 2–3 doses while residual noradrenergic wakefulness and tachycardia stack for up to 12–24 hours—making automatic repeated exposure binges prone to severe anxiety, insomnia, and stimulant psychosis.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
10 mg (oral and mucosal)
Subtle alertness, mild mood elevation, and reduced mental fatigue.
Noticeable mild uptick in heart rate even at low amounts.
10–25 mg (mucosal: 10–20 mg)
Clean wakefulness, talkativeness, sociable confidence, and modest motivation.
Moderate heart-rate increase, appetite suppression, and minimal dry mouth.
25–40 mg (mucosal: 20–40 mg)
Clear dopaminergic mood elevation, social openness, ego boost, and heightened conversational drive.
Sustained ~22 bpm heart-rate and ~21 mmHg systolic BP elevation, sweating, dry mouth, and mild vasoconstriction.
40–60 mg (oral and mucosal)
Scattered hyper-stimulation, compulsive urge to redose, thought acceleration, and rising anxiety on offset.
Strong tachycardia, palpitations, bruxism, muscle tension, difficulty urinating, and temporary erectile dysfunction.
60+ mg (or multiday repeated exposure)
Severe paranoia, panic, delusions, delirious thought disorganization, and rapid-onset stimulant psychosis.
Dangerous hypertension, arrhythmias, chest pain, severe vasoconstriction, hyperthermia, and seizure risk.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Potent NET/DAT reuptake blockade combined with MAO inhibition precipitates severe hypertensive crisis, hyperthermia, and cardiac arrhythmia.
NEP already raises heart rate disproportionately; stacking NDRIs or NBOMes risks acute vasospasm, malignant hypertension, seizures, and heart failure.
Synergistically lowers seizure threshold alongside adrenergic overload.
Elevated Hazard — Avoid
NDRI blockade can interfere with substrate-releaser transport while severely compounding tachycardia, overheating, and neurocardiac strain.
Masks depressant intoxication during NEP's peak, risking sudden blackout and cardiac/electrolyte stress.
Caution / Receptor Attenuation
Frequently triggers rapid heart rate, thought loops, and acute paranoia, especially during NEP's offset.
Heightens palpitations, restlessness, and peripheral vasoconstriction.
Structural Isomer & Sibling Comparison
Compared to its 6-carbon homologue Hexen (NEH), NEP is ~3.5-fold gentler at DAT (hDAT IC50 165 nM vs. 46.7 nM), giving NEP a smoother, less jittery, and slightly more sociable plateau than Hexen. Compared to 3-MMC/4-MMC, NEP is 3–4x more potent by weight (common 25–40 mg vs. 100–200 mg) and acts as a pure reuptake blocker rather than a serotonin releaser. Compared to alpha-PVP/alpha-PiHP, NEP is ~10x less potent at DAT and far more forgiving at 15–30 mg.
Physicochemical Stability & Storage
Physical Form: White to off-white crystalline solid, fine powder, or translucent crystal chunks as the hydrochloride salt. · Soluble in ethanol, DMF, and DMSO.
Store dry and tightly sealed in a light-resistant container at cool room temperature.
Cross-Tolerance & Dependence Profile
mood elevation develops rapid within-session tolerance after 2–3 redoses; cross-tolerant with all dopaminergic stimulants (Hexen, cocaine, pyrovalerones, amphetamines), halving in 3–7 days and resetting in 1–2 weeks. Moderately to highly addictive with strong automatic repeated exposure risk.
Codes on this card
Short meanings for the abbreviations printed with this substance.
DAT
Dopamine transporter
DAT is the protein that collects dopamine back from the gap between nerve cells. A card that names DAT is quoting a laboratory result about that protein.
NET
Norepinephrine transporter
NET is the protein that collects norepinephrine, also called noradrenaline, back into the nerve cell. Cards cite it when a lab report shows activity at that transporter.
SERT
Serotonin transporter
SERT is the protein that collects serotonin back into the nerve cell. A higher number than at DAT means the serotonin transporter needed more concentration to reach the halfway point.
SNDRA / NDRI
Releaser or reuptake blocker
An SNDRA is carried in and the cell releases serotonin, norepinephrine, and dopamine. An NDRI mainly slows the vacuum at norepinephrine and dopamine. The class line says which one the papers describe.
EC₅₀ / IC₅₀
Halfway concentration
EC50 is the concentration where a lab saw half of the maximum measured effect. IC50 is the concentration where it saw half of the maximum block. Smaller means that halfway point came at a lower concentration.
ratio
Selectivity ratio
A selectivity ratio divides two halfway numbers, such as SERT EC50 by DAT EC50, to show which target the assay reached first. The direction of the division has to be stated, or the number flips.
5-HT ↑↑
Serotonergic Overload (Serotonin Toxicity)
A potentially fatal medical emergency caused by excessive synaptic serotonin (for example when mixing two serotonin releasers, MAOIs, or tramadol), marked by hyperthermia and neuromuscular rigidity.
HR / Naczynia
Vasoconstriction & Cardiovascular Load
Narrowing of peripheral blood vessels, elevated blood pressure, and rapid heart rate driven by strong noradrenergic and dopaminergic stimulation.
Chemical Architecture & Structural Profile
NEP (2-(ethylamino)-1-phenylpentan-1-one) is a reference compound belonging to the Cathinone derivatives class, characterized by the molecular formula C13H19NO and a molar mass of 205.3 g/mol. The parent molecule is indexed under CAS registry number 779974-89-9 and in the NCBI PubChem database as CID 205593 (Standard InChIKey: QQAHEGDXEXIQPR-UHFFFAOYSA-N).
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), NEP is indexed within the Cathinone structural group. Toxicological notes (PsychonautWiki): exact toxic threshold is unknown. Dependence liability (PsychonautWiki): moderately addictive with a high potential for abuse. Documented cross-tolerance class: dopamine, stimulant. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- Riksdagen — Förordning (1999:58) om förbud mot vissa hälsofarliga varor — Sveriges riksdag (2026-11-12)